HarryWilliamLampirisMD

PubMed

• 1 citations
  Association between household exposure and cycle threshold in COVID-19 infected health care workers
  Ai Chien, Sandra J Domeracki, Sandeep Guntur, Kristopher Taylor, Chuanyi M. Lu, Harry Lampiris, Paul D. Blanc> ;Journal of Occupational Medicine and Toxicology. 2021 Aug 4
• 11 citations
  Cycle Threshold to Test Positivity in COVID-19 for Return to Work Clearance in Health Care Workers.
  Sandra J Domeracki, Robert N Clapp, Kristopher Taylor, Chuanyi M. Lu, Harry Lampiris, Paul D. Blanc> ;Journal of Occupational and Environmental Medicine. 2020 Nov 1
• 3 citations
  Evaluating the Concordance of Clinician Antiretroviral Prescribing Practices and HIV-ASSIST, an Online Clinical Decision Support Tool.
  Jesus A. Ramirez, Manoj V. Maddali, Jehan Z Budak, Jonathan Z. Li, Harry Lampiris, Maunank Shah> ;Journal of General Internal Medicine. 2020 May 1
• 5 citations
  Opportunistic coinfection with Pneumocystis jirovecii and Coccidioides immitis associated with idelalisib treatment in a patient with chronic lymphocytic leukaemia
  Lindsey M Ward, Michael J. Peluso, Jehan Z Budak, Brett M. Elicker, Peter Chin-Hong, Harry Lampiris, Jennifer S Mulliken> ;BMJ Case Reports. 2020 Apr 1
• Response to: Is Burnout Infectious? Understanding Drivers of Burnout and Job Satisfaction Among Academic Infectious Diseases Physicians.
  Jehan Z Budak, Cristina Brickman, Emily Abdoler, Erika Wallender, Jennifer S Mulliken, Andrew D. Kerkhoff, Harry Lampiris, Jennifer M. Babik, Catherine A. Koss, Brian ...> ;Open Forum Infectious Diseases. 2020 Apr 6
• 204 citations
  HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing
  Steven A. Yukl, Philipp Kaiser, Peggy Kim, Sushama Telwatte, Sunil K. Joshi, Mai Vu, Harry Lampiris, Joseph K. Wong> ;Science Translational Medicine. 2018 Feb 28
• 75 citations
  Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation
  Peilin Li, Philipp Kaiser, Harry Lampiris, Peggy Kim, Steven A. Yukl, Diane V. Havlir, Warner C. Greene, Joseph K. Wong> ;Nature Medicine. 2016 Jul 1
• Neuraminidase Inhibitors and Influenza Infection—Reply
  Janice K. Louie, Harry Lampiris> ;JAMA Internal Medicine. 2016 Mar 1
• 7 citations
  Treating Influenza With Neuraminidase Inhibitors: What Is the Evidence?
  Janice K. Louie, Harry Lampiris> ;JAMA Internal Medicine. 2015 Dec 1
• 2137 citations
  Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a c...
  Daniel D Murray, Kazuo Suzuki, Matthew Law, Jonel Trebicka, Jacquie Neuhaus, Deborah Wentworth, Margaret Johnson, Michael J. Vjecha, Anthony D. Kelleher, Sean Emery, B...> ;Plos One. 2015 Oct 14
• 155 citations
  Geriatric Syndromes in Older HIV-Infected Adults.
  Meredith Greene, Kenneth E. Covinsky, Victor Valcour, Yinghui Miao, Joy Madamba, Harry Lampiris, Irena Stijacic Cenzer, Jeffrey N. Martin, Steven G. Deeks> ;Journal of Acquired Immune Deficiency Syndromes. 2015 Jun 1
• 78 citations
  The Montreal Cognitive Assessment: A Pilot Study of a Brief Screening Tool for Mild and Moderate Cognitive Impairment in HIV-Positive Veterans
  Maggie Chartier, Pierre-Cedric Crouch, Van Tullis, Stephanie Catella, Erin Frawley, Charles Filanosky, Timothy P. Carmody, John R. McQuaid, Harry Lampiris, Joseph K. Wong> ;Journal of the International Association of Providers of AIDS Care. 2015 May 1
• 128 citations
  Management of Human Immunodeficiency Virus Infection in Advanced Age
  Meredith Greene, Amy C. Justice, Harry Lampiris, Victor Valcour> ;JAMA. 2013 Apr 3
• 21 citations
  Elvitegravir: a once-daily, boosted, HIV-1 integrase inhibitor.
  Harry Lampiris> ;Expert Review of Anti-Infective Therapy. 2012 Jan 1
• 7 citations
  Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter
  Steven A. Yukl, Peilin Li, Katsuya Fujimoto, Harry Lampiris, Chuanyi M. Lu, C. Bradley Hare, Steven G. Deeks, Teri Liegler, Mark Pandori, Diane V. Havlir, Joseph K. Wong> ;Journal of Virological Methods. 2011 Aug 1
• 165 citations
  A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response
  Hiroyu Hatano, Timothy L. Hayes, Viktor Dahl, Elizabeth Sinclair, Tzong-Hae Lee, Rebecca Hoh, Harry Lampiris, Peter W. Hunt, Sarah Palmer, Joseph M. McCune, Jeffrey N....> ;The Journal of Infectious Diseases. 2011 Apr 1
• 902 citations
  The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
  Yang, O. O., Florencia Pereyra, Xiaoming Jia, Paul J. McLaren, Amalio Telenti, de Bakker Pi, Bruce D. Walker, Stephan Ripke, Chanson J. Brumme, Sara L. Pulit, Mary Car...> ;Science. 2010 Dec 10
• 234 citations
  Differences in HIV Burden and Immune Activation within the Gut of HIV-Positive Patients Receiving Suppressive Antiretroviral Therapy
  Steven A. Yukl, Sara Gianella, Elizabeth Sinclair, Lorrie Epling, Qingsheng Li, Lijie Duan, Alex Choi, Valerie Girling, Terence Ho, Peilin Li, Katsuya Fujimoto, Harry ...> ;The Journal of Infectious Diseases. 2010 Nov 15
• 194 citations
  Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
  Steven A. Yukl, Amandeep K. Shergill, Kenneth R. McQuaid, Sara Gianella, Harry Lampiris, C Hare, Mark Pandori, Elizabeth Sinclair, Huldrych F. Günthard, Marek Fischer,...> ;AIDS. 2010 Oct 23
• 55 citations
  Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy.
  Hiroyu Hatano, Harry Lampiris, Signe Fransen, Soumi Gupta, Wei Huang, Rebecca Hoh, Jeffrey N. Martin, Jacob Lalezari, David R. Bangsberg, Christos J. Petropoulos, Stev...> ;Journal of Acquired Immune Deficiency Syndromes. 2010 Aug 1
• 101 citations
  Activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV type 1: results of a phase 2, randomized, controlled, dose-ranging clinical trial.
  Andrew R. Zolopa, Daniel S Berger, Harry Lampiris, Lijie Zhong, Steven L. Chuck, Jeffrey Enejosa, Brian P. Kearney, Andrew K. Cheng> ;The Journal of Infectious Diseases. 2010 Mar 15
• 107 citations
  Evidence for ongoing brain injury in human immunodeficiency virus–positive patients treated with antiretroviral therapy
  Valerie A. Cardenas, Dieter J. Meyerhoff, Colin Studholme, John Kornak, Johannes C. Rothlind, Harry Lampiris, John Neuhaus, Robert M. Grant, Linda L. Chao, Diana Trura...> ;Journal of Neurovirology. 2009 Aug 27
• 276 citations
  Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
  Dunne, M. W., Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin, Irina Konourina, Andy I. M. Hoepelman, Harry Lampiris, Bernard Hirschel, Pablo Tebas, François Raffi, Be...> ;The New England Journal of Medicine. 2008 Oct 2
• 3 citations
  Resolution of Hepatitis C Virus-Induced Steatosis Improves Tolerability of Antiretroviral Drugs Associated with Hepatotoxicity in an HIV-Infected Individual
  Tina Shah, Harry Lampiris, Mai Vu, Alexander Monto, Phyllis C. Tien> ;The Journal of Infectious Diseases. 2008 Mar 15
• 528 citations
  Relationship between T Cell Activation and CD4+ T Cell Count in HIV-Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy
  Peter W. Hunt, Jason M. Brenchley, Elizabeth Sinclair, Joseph M. McCune, Michelle E. Roland, Kimberly Page-Shafer, Priscilla Y. Hsue, Brinda Emu, Melissa R. Krone, Har...> ;The Journal of Infectious Diseases. 2008 Jan 1
• Join now to see all